Compare PSTV & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PSTV | LCFY |
|---|---|---|
| Founded | 1996 | 2009 |
| Country | United States | Australia |
| Employees | N/A | 18 |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9M | 8.4M |
| IPO Year | 2016 | N/A |
| Metric | PSTV | LCFY |
|---|---|---|
| Price | $3.10 | $4.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $191.67 | N/A |
| AVG Volume (30 Days) | ★ 4.4M | 12.9K |
| Earning Date | 03-12-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.61 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,213,000.00 | N/A |
| Revenue This Year | $21.93 | N/A |
| Revenue Next Year | $279.39 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.13 | $2.50 |
| 52 Week High | $3.84 | $13.98 |
| Indicator | PSTV | LCFY |
|---|---|---|
| Relative Strength Index (RSI) | 81.08 | 57.91 |
| Support Level | $0.39 | $4.67 |
| Resistance Level | N/A | $4.80 |
| Average True Range (ATR) | 0.16 | 0.26 |
| MACD | 0.35 | -0.01 |
| Stochastic Oscillator | 80.06 | 85.23 |
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
Locafy Ltd is an Australian company currently focused on commercializing its Software as a Service (SaaS) online marketing technology (Technology), which prominently delivers a cost-effective location-based digital marketing solution for small businesses in the key markets of the USA, Australia and Canada. The company has two operating segments: Publishing and SEO Agency. The company derives the majority of its revenue from license subscription fees and advertising fees. Geographically, the maximum revenue is derived from North America.